Article

dailyvoiceplus.com on 2019-08-05 14:35

Shelton pharma company’s shingles treatment ready for human clinical trials

Shelton pharmaceutical company NanoViricides has announced that its first drug candidate, NV-HHV-101, is on track with required preclinical GLP ...

Related news